ReviewDrugs & aging2020

Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk.

Suraj Rajasimhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.